GGrantIndex
Sort

25,944 grants matching neurodegeneration

GLYCEROPHOSPHOLIPIDS

$468,690
Alex Brown · University Of California, San Diego · U54 · FY2009 · GM

Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations

$468,685
Antonio Sanz-Clemente · Drexel University · R01 · FY2024 · AG

Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations

$468,685
Antonio Sanz-Clemente · Drexel University · R01 · FY2022 · AG

Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations

$468,685
Antonio Sanz-Clemente · Drexel University · R01 · FY2023 · AG

Dominantly Inherited Alzheimer Network: Project 3

$468,629
Anne Fagan Niven · Washington University · U19 · FY2022 · AG

Regulation of Gene Expression During Stress

$468,555
Maria Hatzoglou · Case Western Reserve University · R01 · FY2008 · DK

BEHAVIORAL CHARACTERIZATION OF ACUTE&CHRONIC AMPHETAMINE

$468,494
University Of California San Diego · R01 · FY2002 · DA

Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain

$468,207
Mikhail Y Golovko · University Of North Dakota · R01 · FY2021 · NS

Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain

$468,207
Mikhail Y Golovko · University Of North Dakota · R01 · FY2025 · NS

Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain

$468,207
Mikhail Y Golovko · University Of North Dakota · R01 · FY2022 · NS

Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain

$468,207
Mikhail Y Golovko · University Of North Dakota · R01 · FY2023 · NS

ALGORITHMS FOR FUNCTIONAL AND ANATOMICAL BRAIN ANALYSIS

$468,187
Michael I Miller · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2011 · RR

Gene-Environment Interactions in Neurodegenerative Disease

$468,000
Vanessa A Fitsanakis · Northeast Ohio Medical University · R15 · FY2017 · ES

Yeast-based HTS Assay Technologies for Proteases

$467,998
John C Reed · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · AI

Yeast-based HTS Assay Technologies for Proteases

$467,998
John C Reed · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · AI

Discovery of apoE4 modulators for Alzheimer’s disease therapy

$467,938
Yonghe Li · Mayo Clinic Jacksonville · R01 · FY2022 · AG

Identification of genes related to spcific properties of mammalian cells

$467,914
Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

The Cdk5/35 Kinase

$467,860
Li-Huei Tsai · Massachusetts Institute Of Technology · R37 · FY2018 · NS

The Cdk5/35 Kinase

$467,860
Li-Huei Tsai · Massachusetts Institute Of Technology · R37 · FY2019 · NS

The Cdk5/35 Kinase

$467,860
Li-Huei Tsai · Massachusetts Institute Of Technology · R37 · FY2017 · NS

Impact of vascular apoE in aging and AD

$467,827
Takahisa Kanekiyo · Mayo Clinic Jacksonville · U19 · FY2024 · AG

Neurotoxicity of Reactive Astrocyte-secreted Lipids in Neurodegenerative Disease

$467,770
Shane Liddelow · New York University School Of Medicine · R01 · FY2022 · EY

Lyme neuroborreliosis pathogenesis in the rhesus monkey

$467,536
Tulane University Of Louisiana · R01 · FY2004 · NS

Gene Therapy And Neurodegeneration

$467,499
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2015 · DA

Project 1: Tau metabolism: molecular chaperones, targeting and proteolysis

$467,433
Aimee Kao · University Of California, San Francisco · U54 · FY2021 · NS